Veradigm Total Long-Term Assets 2010-2022 | MDRX
Veradigm total long-term assets from 2010 to 2022. Total long-term assets can be defined as the sum of all assets classified as non-current
| Veradigm Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2022 | $825 |
| 2021 | $1,662 |
| 2020 | $1,764 |
| 2019 | $2,364 |
| 2018 | $2,323 |
| 2017 | $3,373 |
| 2016 | $3,228 |
| 2015 | $2,144 |
| 2014 | $1,977 |
| 2013 | $2,080 |
| 2012 | $1,777 |
| 2011 | $1,846 |
| 2010 | $1,843 |
| 2010 | $687 |
| 2009 | $692 |
| Veradigm Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2022-12-31 | $825 |
| 2022-09-30 | $880 |
| 2022-06-30 | $885 |
| 2022-03-31 | $890 |
| 2021-12-31 | $1,662 |
| 2021-09-30 | $1,679 |
| 2021-06-30 | $1,699 |
| 2021-03-31 | $1,736 |
| 2020-12-31 | $1,764 |
| 2020-09-30 | $2,197 |
| 2020-06-30 | $2,319 |
| 2020-03-31 | $2,346 |
| 2019-12-31 | $2,364 |
| 2019-09-30 | $2,456 |
| 2019-06-30 | $2,431 |
| 2019-03-31 | $2,408 |
| 2018-12-31 | $2,323 |
| 2018-09-30 | $3,674 |
| 2018-06-30 | $3,498 |
| 2018-03-31 | $3,459 |
| 2017-12-31 | $3,373 |
| 2017-09-30 | $3,215 |
| 2017-06-30 | $3,161 |
| 2017-03-31 | $3,172 |
| 2016-12-31 | $3,228 |
| 2016-09-30 | $3,220 |
| 2016-06-30 | $3,116 |
| 2016-03-31 | $2,085 |
| 2015-12-31 | $2,144 |
| 2015-09-30 | $2,123 |
| 2015-06-30 | $2,164 |
| 2015-03-31 | $1,947 |
| 2014-12-31 | $1,977 |
| 2014-09-30 | $2,022 |
| 2014-06-30 | $2,050 |
| 2014-03-31 | $2,092 |
| 2013-12-31 | $2,080 |
| 2013-09-30 | $2,083 |
| 2013-06-30 | $2,082 |
| 2013-03-31 | $2,004 |
| 2012-12-31 | $1,777 |
| 2012-09-30 | $1,776 |
| 2012-06-30 | $1,826 |
| 2012-03-31 | $1,833 |
| 2011-12-31 | $1,846 |
| 2011-09-30 | $1,833 |
| 2011-06-30 | $1,837 |
| 2011-03-31 | $1,847 |
| 2010-12-31 | $1,843 |
| 2010-09-30 | $1,827 |
| 2010-06-30 | |
| 2010-05-31 | $687 |
| 2010-03-31 | |
| 2010-02-28 | $682 |
| 2009-12-31 | $683 |
| 2009-11-30 | $683 |
| 2009-09-30 | |
| 2009-08-31 | $689 |
| 2009-05-31 | $692 |
| 2009-02-28 | $695 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.486B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.971B | 53.83 |
| Hims & Hers Health (HIMS) | United States | $11.505B | 119.54 |
| Tempus AI (TEM) | United States | $11.232B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.506B | 70.41 |
| IRhythm Technologies (IRTC) | United States | $4.374B | 0.00 |
| Privia Health (PRVA) | United States | $3.041B | 208.92 |
| Clover Health Investments (CLOV) | United States | $1.916B | 0.00 |
| Enovis (ENOV) | United States | $1.889B | 10.53 |
| Schrodinger (SDGR) | United States | $1.744B | 0.00 |
| Phreesia (PHR) | United States | $1.492B | 0.00 |
| Azenta (AZTA) | United States | $1.266B | 58.96 |
| Omnicell (OMCL) | United States | $1.189B | 20.98 |
| 10x Genomics (TXG) | United States | $1.055B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.565B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Standard BioTools (LAB) | United States | $0.424B | 0.00 |
| TruBridge (TBRG) | United States | $0.374B | 833.33 |
| Claritev (CTEV) | United States | $0.350B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.293B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.211B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| Pulmonx (LUNG) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.086B | 0.00 |
| CareCloud (CCLD) | United States | $0.078B | 2.97 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |